Old Web
English
Sign In
Acemap
>
authorDetail
>
M Bulatovic-Calasan
M Bulatovic-Calasan
Medicine
Internal medicine
Methotrexate
Pharmacology
Coronavirus disease 2019
8
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neutraliserende monoklonale antilichamen bij COVID-19
2021
L. M. L. Stolk
M Bulatovic-Calasan
Show All
Source
Cite
Save
Citations (0)
Drugs for COVID-19: tocilizumab
2021
EP Schwarz
LL Krens
M Bulatovic-Calasan
Show All
Source
Cite
Save
Citations (0)
Drugs for COVID-19
2020
F. van Stiphout
LL Krens
M Bulatovic-Calasan
TM Bosch
Show All
Source
Cite
Save
Citations (0)
PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
2013
Pediatric Rheumatology
P. van Dijkhuizen
M Bulatovic-Calasan
S.M.F. Pluijm
M.C. de Rotte
Bas Vastert
S. Kamphuis
R. de Jonge
N Wulffraat
Show All
Source
Cite
Save
Citations (0)
AB0307 Low prevalence of methotrexate intolerance in patients with rheumatoid and psoriatic arthritis
2013
Annals of the Rheumatic Diseases
M Bulatovic-Calasan
O. F. C. van den Bosch
M.C. Creemers
M. Custers
T.H. Heurkens
J M van Woerkom
Nico Wulffraat
Show All
Source
Cite
Save
Citations (0)
1